{"id":"W2150458484","doi":"10.1002/wps.20252","title":"Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis","year":2015,"lang":"en","type":"review","venue":"World Psychiatry","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1244,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"University of California, San Diego; Kuopion Yliopistollinen Sairaala; University of Rochester; Postgraduate Institute of Medical Education and Research, Chandigarh; University of Toronto; Medical Center, University of Rochester; Newcastle University; Taipei Medical University; Vrije Universiteit Amsterdam; Universiteit Utrecht; Rijksuniversiteit Groningen; Yale University; University of Pittsburgh","keywords":"Amisulpride; Bipolar disorder; Medicine; Schizophrenia (object-oriented programming); Clozapine; Olanzapine; Psychiatry; Aripiprazole; Metabolic syndrome; Antipsychotic; Population; Major depressive disorder; Bipolar I disorder; Meta-analysis; Quetiapine; Internal medicine; Obesity; Mania; Lithium (medication); Mood","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}